Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis

Cisplatin is a chemotherapeutic drug commonly used in clinics. However, acquired resistance confines its application in chemotherapeutics. To overcome the acquired resistance to cisplatin, it is reasoned, based on our previous findings of mediation of cellular responses by [Gd@C(82)(OH)(22)](n) nano...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Liang, Xing-Jie, Meng, Huan, Wang, Yingze, He, Haiyong, Meng, Jie, Lu, Juan, Wang, Paul C., Zhao, Yuliang, Gao, Xueyun, Sun, Baoyun, Chen, Chunying, Xing, Genmei, Shen, Dingwu, Gottesman, Michael M., Wu, Yan, Yin, Jun-jie, Jia, Lee
Format: Artigo
Język:Inglês
Wydane: National Academy of Sciences 2010
Hasła przedmiotowe:
Biological Sciences
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2867714/
https://ncbi.nlm.nih.gov/pubmed/20368438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0909707107
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy